An Opinion Editorial from Jorge D. Faccinetti – Co-founder and Chief Editor – In today’s publishing landscape, one thing is clear: artificial intelligence and machine learning are advancing at dizzying speeds. Keeping up with these developments and understanding their true impact on our work and lives has become increasingly challenging.
This week we bring you my chats from ENDO 2025 with Jill Sisco, president of the Acromegaly Community, Dr. Chris Yedinak, retired professor at Oregon Health and Science University, adjunct professor at Mount Marty University, and Alan Erck, Chief Commercial Officer at Anovo Pharmacy. Learn their outlook for patient care and support.
Can Artificial Intelligence make medical research easier to understand? This is a fascinating question that we grapple with daily as we navigate the reality of an AI-driven publishing landscape. We’ll have more to say on this subject in the future, but for now, we want to share an AI-generated output in the form of a podcast, completely created by artificial intelligence, including all voices, tonality, and content. Even the visual representations of the two podcasters aren’t real. These people don’t exist. Ponder the implication of that notion for a while.
We caught up with a group of top executives at Recordati at ENDO 2025 and asked them about their plans, challenges and opportunities and, importantly, their outlook for new therapies in acromegaly and Cushing’s.
Through our conversations with leading pituitary experts, physicians, nurses, industry executives, researchers, patient advocates, and other key stakeholders, we gain unique insights from the fascinating world of pituitary disease research and treatment.
From Linda M Rio, PWN contributor and mental health professional – I’m often contacted by those with an already diagnosed pituitary disorder or those who are searching for help and suspect they are impacted but
In today’s podcast, Dr. Lewis Blevins dives into the fascinating findings from a study by Corcept Therapeutics on the prevalence of hypercortisolism in people with type 2 diabetes.
This is a very informative discussion about the new indications of the Cushing’s Drug Isturisa® (osilodrostat) with Dr. Mario Maldonado, who heads global development for endocrinology at Recordati Rare Diseases.
There is growing interest in the use of cortisol pumps to treat patients with adrenal insufficiency, though most physicians in the US lack experience in this area. Dr. Lewis Blevins caught up with Dr. Naila Goldenberg at The Endocrine Society Meeting in San Francisco, California, in July 2025.
Dr. Lewis Blevins caught up with Dr. Francesca Galbiati at The Endocrine Society Meeting in San Francisco, California in July 2025. In this video she reviews her work relating to the effects of intranasal oxytocin on sex steroid levels in obese patients.
Dr. Lewis Blevins talks with Dr. Iacopo Chiodini at The Endocrine Society Meeting in San Francisco, California to discuss his presentation illustrating the benefits of adrenalectomy in patients with MACS. In this video, capturing the presentation of data, they also discuss the need for studies to address the medical management of patients with MACS.